Korea United Pharm took legal action to protect its patent of antitussive drug Levotics CR Tab. (levodropropizine) against generic copies.The company said on Tuesday that it filed a lawsuit against 15 generic drugmakers that allegedly infringed upon the patent of Levotics CR Tab.Korea United Pharm d
GC Labcell said that it has published a paper related to genetically engineered support cells, one of its culture platform technologies, in the latest issue of Cellular & Molecular Immunology.“This paper is about a unique technology for support cells that induce proliferation and activity of natural
Myongji Hospital said it would start a free support project for dementia screening for older adults in medical blind spots.Under an agreement signed on Tuesday, Myongji Hospital and Goyang City will conduct a dementia differential test for seniors from low-income families in the city through the ear
Daewoong Pharmaceutical and Daiichi Sankyo Korea said they have found no azido methyl biphenyl tetrazole (AZBT) in 21 olmesartan drugs for high blood pressure during the recent inspection.The two companies performed the inspection following Health Canada's measure to recall treatments after detectin
AstraZeneca’s Lynparza tablet (ingredient: olaparib), a poly adenosine diphosphate-ribose polymerase (PARP) inhibitor, has become reimbursable for the first- and second-line maintenance therapy in ovarian cancer patients.The anticancer drug shifted its form from capsule to tablet and obtained health
The government has reaffirmed its position to return to normal life in phases, as it is difficult to maintain the current social distancing measure against Covid-19.A top health official said Tuesday that Korea might be able to adopt the "live-with-covid” regime from late October or early November."
GE Healthcare Korea said it has entered a strategic partnership with SK Telecom to build digital healthcare infrastructure in Korea.Through this partnership, the two companies will cooperate in exchanging and operating related technologies to realize digital healthcare solutions and the commercializ
Hanall Biopharma has begun administrating HL161 (ingredient: batoclimab) in phase 3 clinical trials conducted in China for treating myasthenia gravis. Harbour Biomed, Hanall Biopharm’s Chinese partner, is conducting clinical trials in patients with a rare long-term condition that causes muscle weakn
A research team at Severance Hospital has developed a cell membrane-derived nanoparticle (CMNP) capable of preserving the larynx in laryngeal cancer.The hospital said that intercellular interactions help cell growth, differentiation, and tissue regeneration and affect cancer development and metastas
Korea Health Industry Development Institute (KHIDI) and the Korean Embassy in Washington will host a seminar to help domestic companies advance to Boston Biocluster at Cambridge Marriott Hotel, Boston, next Friday. The workshop will be held by the Ministry of Health and Welfare’s Medical Korea base
A Seoul National University Bundang Hospital (SNUBH) research team has developed an algorithm that can predict acute kidney injury in patients who have received kidney cancer surgery.Acute kidney injury is a disease in which renal function weakens due to sudden damage to the kidney cells. If not tre
About 27 percent of local epilepsy patients have drug-resistant epilepsy (DRE), and the nation needs to actively introduce new anti-epileptic drugs (AEDs) to treat them effectively, neurologists said. DRE refers to a condition when two AEDs have failed to control seizures.Korean Epilepsy Society’s (
Second-generation renal denervation (RDN), using high-frequency sound waves, can lower blood pressure significantly and consistently with excellent safety in patients with intractable hypertension that is difficult to treat with antihypertensive drugs, local researchers said in a study.RDN could be
Local developers of Covid-19 vaccines have announced plans to conduct large-scale, late-stage global trials, raising expectations for homegrown Covid-19 vaccines.However, some companies have to overcome several challenges, and it will take some time to commercialize a local Covid-19 vaccine, observe
Daewon Pharmaceutical said that it found TG Fenon (Ingredient: fenofibrate choline) significantly reduces triglyceride levels, reaffirming its safety in phase 4 clinical trial of treating patients with hypertriglyceridemia.The company compared triglyceride reduction between patient groups that recei
Korea University Anam Hospital (KUAH) said its neurosurgery team is drawing the attention of academia with the study results of regenerative therapies, including the finding of new mediators for the stem cell therapy of ischemic stroke.The research team, led by Professor Park Dong-hyuk, has made sig
The government said that it would provide booster shots for those vulnerable to the Covid-19 virus from next month to increase the inoculation effect of the vaccine and deal with the more contagious Delta variant.A booster shot refers to receiving an additional vaccine jab after a certain point in t
Novartis’ CDK4/6 inhibitor Kisqali (ribociclib), combined with letrozole, extended overall survival by more than one year in patients with hormone receptor-positive, human epidermal growth factor 2-negative (HR+/HER2-) advanced breast cancer.The company released the results of phase 3 MONALEESA-2 tr
Asan Medical Center (AMC) has been included in the top 50 global hospitals in eight of the 10 specialized treatments, according to Newsweek.The U.S. weekly news magazine rates each hospital through an online survey conducted by Statista, a German market surveyor and consumer data agency, on tens of
The number of patients treated for heart diseases caused by myocardial ischemia sharply grew in Korea over the past five years, significantly increasing medical expenses for their treatment, data showed.According to the National Health Insurance Service, the number of patients with ischemic heart di